Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs  McDermott Niamh , Meunier Armelle , Wong Simon , Buchete.

Slides:



Advertisements
Similar presentations
Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.
Advertisements

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
Fig. 4. miR-326, miR-330, and miR-3099 bound to the GFAP 3'-UTR and regulated GFAP expression. (A) Schematic diagram of potential binding sequence (seed.
miR p Is a Novel Prognostic Biomarker of Prostate Cancer
Cell Physiol Biochem 2013;32: DOI: /
MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers  Thomas X. Lu,
Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells  Brita Singers Sørensen, Morten Busk, Nadine Olthof, Ernst-Jan Speel,
Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma  Kuang-Tzu Huang, I-Ying Kuo, Ming-Chao.
Correlation between urinary dose and delayed radiation cystitis after 78Gy intensity- modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up.
Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions  Asako Ichihara, MD, PhD, Zhongzhi Wang, PhD, Masatoshi Jinnin,
In cancer cell lines inhibition of SCF/c-Kit pathway leads to radiosensitization only when SCF is strongly over-expressed  Fabian Eberle, Florian H. Leinberger,
Differential Expression of Circular RNAs in Glioblastoma Multiforme and Its Correlation with Prognosis  Junle Zhu, Jingliang Ye, Lei Zhang, Lili Xia,
Detecting new microRNAs in human osteoarthritic chondrocytes identifies miR-3085 as a human, chondrocyte-selective, microRNA  N. Crowe, T.E. Swingler,
Circulating Exosomal miR-17-5p and miR-92a-3p Predict Pathologic Stage and Grade of Colorectal Cancer  Fangfang Fu, Weiqin Jiang, Linfu Zhou, Zhi Chen 
Strong radioprotective FGF1 signaling down-regulates proliferative and metastatic capabilities of the angiosarcoma cell line, ISOS-1, through the dual.
N. Zhong, J. Sun, Z. Min, W. Zhao, R. Zhang, W. Wang, J. Tian, L
MicroRNA profiling in duodenal ulcer disease caused by Helicobacter pylori infection in a Western population  S. Lario, M.J. Ramírez-Lázaro, A.M. Aransay,
Volume 8, Issue 1, Pages (July 2014)
MicroRNA221-3p modulates Ets-1 expression in synovial fibroblasts from patients with osteoarthritis of temporomandibular joint  J. Xu, Y. Liu, M. Deng,
Volume 21, Issue 13, Pages (December 2017)
Improved outcome of treating locally advanced lung cancer with the use of Lattice Radiotherapy (LRT): A case report  Beatriz E. Amendola, Naipy C. Perez,
The impact of the IGF-1 system of cancer cells on radiation response – An in vitro study  Senthiladipan Venkatachalam, Esther Mettler, Christian Fottner,
MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers  Thomas X. Lu,
Elevated levels of miR-145 correlate with SMAD3 down-regulation in Cystic Fibrosis patients  Francesca Megiorni, Samantha Cialfi, Giuseppe Cimino, Riccardo.
Clinical and Translational Radiation Oncology
MicroRNA profiling in duodenal ulcer disease caused by Helicobacter pylori infection in a Western population  S. Lario, M.J. Ramírez-Lázaro, A.M. Aransay,
Volume 67, Issue 1, Pages 7-10 (January 2015)
ATM Gene Mutations Result in Both Recessive and Dominant Expression Phenotypes of Genes and MicroRNAs  Denis A. Smirnov, Vivian G. Cheung  The American.
Regulating Cancer Stem Cells the miR Way
Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin.
Bringing IDH into the Fold
Volume 135, Issue 1, Pages (July 2008)
VMAT radiation-induced nausea and vomiting in adjuvant breast cancer radiotherapy: The incidental effect of low-dose bath exposure  G. Lazzari, A. Terlizzi,
Overcoming resistance of cancer stem cells
Action Levels on Dose and Anatomic Variation for Adaptive Radiation Therapy Using Daily Offline Plan Evaluation: Preliminary Results  Baoshe Zhang, PhD,
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2  Ji-guang Zhang,
Clinical and Translational Radiation Oncology
Simultaneous integrated prophylactic cranial irradiation in sino-nasal cancer  Kenneth Jensen, Maja Bendtsen Sharma, Simon Lenler-Eriksen, Per Friis, Anne.
The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and.
Follow up results of a prospective study to evaluate the impact of FDG-PET on CT- based radiotherapy treatment planning for oesophageal cancer  Sweet Ping.
Volume 23, Issue 7, Pages (May 2018)
Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells  Tomer Halevy, Christian Czech, Nissim.
Radiomic analysis in prediction of Human Papilloma Virus status
Volume 54, Issue 5, Pages (June 2014)
Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results.
Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung.
Upregulation of Hypoxia-Inducible Factor-1α mRNA and its Clinical Significance in Non- small Cell Lung Cancer  Tomofumi Yohena, MD, Ichiro Yoshino, MD,
Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx:
Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer  Katrina Woodford, Vanessa Panettieri, Trieumy Tran Le,
Jean-Emmanuel Bibault, Ingeborg Tinhofer 
Molecular prognostication of liver cancer: End of the beginning
Volume 9, Issue 5, Pages (November 2017)
847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach    Molecular.
Use of MicroRNA Expression Levels to Predict Outcomes in Resected Stage I Non- small Cell Lung Cancer  Eric Duncavage, MD, Boone Goodgame, MD, Ananth Sezhiyan,
Assessment of the role of translationally controlled tumor protein 1 (TPT1/TCTP) in breast cancer susceptibility and ATM signaling  Katharina Neuhäuser,
Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas  Debra Nana Yeboa, James B. Yu,
Volume 130, Issue 3, Pages (September 2013)
ATM Gene Mutations Result in Both Recessive and Dominant Expression Phenotypes of Genes and MicroRNAs  Denis A. Smirnov, Vivian G. Cheung  The American.
Clinical application of Total Skin Electron Beam (TSEB) therapy for the management of T cell cutaneous lymphomas. The evolving role of low dose (12 Gy)
miR-330-5p Targets Tyrosinase and Induces Depigmentation
Assessing Genetic Expression Profiles in Melanoma Diagnosis
Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients  Line Brøndum, Jesper Grau Eriksen, Brita Singers Sørensen,
Fiona T van den Berg, John J Rossi, Patrick Arbuthnot, Marc S Weinberg 
Volume 6, Issue 3, Pages (March 2016)
MiR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1  Qi Song, Quanbo Ji, Jingbo Xiao, Fang Li, Lingxiong Wang, Yin.
Radiation dose mapping and anastomotic complications after trimodality therapy for esophageal cancers  Andrew Bang, Joel A. Broomfield, Jessica Chan,
S Ekeloef, M. H. H. Larsen, A. M. V
Clinical and Translational Radiation Oncology
Targeting DCLK1 by miRNA-137.
Michael Yan, Weidong Kong, Andrew Kerr, Michael Brundage 
Presentation transcript:

Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs  McDermott Niamh , Meunier Armelle , Wong Simon , Buchete Vio , Marignol Laure   Clinical and Translational Radiation Oncology  Volume 2, Pages 63-68 (February 2017) DOI: 10.1016/j.ctro.2017.01.005 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 Radiation survival curves and miRNA profiling of the 22Rv1 cell lines panel. Surviving fraction of the radiation resistant (RR-22RV1), wild type (WT-22RV1), 22Rv1 age matched control (AMC-22RV1) and hypoxic (H-22Rv1) cells in response to single radiation doses of up to 6Gy. Mean±SEM, *p⩽0.05. Clinical and Translational Radiation Oncology 2017 2, 63-68DOI: (10.1016/j.ctro.2017.01.005) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 Schematic representation of miRNAs profiles analysis. Clinical and Translational Radiation Oncology 2017 2, 63-68DOI: (10.1016/j.ctro.2017.01.005) Copyright © 2017 The Authors Terms and Conditions

Fig. 3 Validation of miR-210 and miR-4284 expression patterns in radioresistant 22Rv1 cells. Fold change in mRNA expression of (A) miR-201 and (B) miR-4284 in RR-22Rv1, AMC-22Rv1 and H-22Rv1 relative to WT-22Rv1 cells. Clinical and Translational Radiation Oncology 2017 2, 63-68DOI: (10.1016/j.ctro.2017.01.005) Copyright © 2017 The Authors Terms and Conditions

Fig. 4 Correlation between miR-4284 expression and target gene expression. The fold change in miR-4284 expression following transfection of 22Rv1 cells with a miR-4284 mimic when compared to untransfected controls are plotted against the measured fold change in expression of predicted miR-4284 target genes in individual sample replicates. The relationship was analysed using a Pearson correlation: Pearson r coefficient and R2 values are presented. Clinical and Translational Radiation Oncology 2017 2, 63-68DOI: (10.1016/j.ctro.2017.01.005) Copyright © 2017 The Authors Terms and Conditions